Nurix Therapeutics
NRIX
NRIX
173 hedge funds and large institutions have $1.36B invested in Nurix Therapeutics in 2024 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 61 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9.17% more ownership
Funds ownership: 100.4% → 109.57% (+9.2%)
54% less call options, than puts
Call options by funds: $1.05M | Put options by funds: $2.28M
Holders
173
Holding in Top 10
4
Calls
$1.05M
Puts
$2.28M
Top Buyers
| 1 | +$62M | |
| 2 | +$46.7M | |
| 3 | +$45.7M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$26.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.7M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$11.3M | |
| 3 | -$9.41M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$7.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$7.58M |